Recombinant Vaccine Market to Surge on DNA Breakthroughs
The recombinant vaccine market encompasses vaccines produced by genetic engineering techniques, where target antigen genes are inserted into host cells to generate immunogenic proteins. These vaccines offer high purity, scalability and consistent batch-to-batch quality compared to traditional live-attenuated or inactivated vaccines. Subunit vac